Literature DB >> 2783345

Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate.

B A Claesson1, R Schneerson, J B Robbins, J Johansson, T Lagergard, J Taranger, D Bryla, L Levi, T Cramton, B Trollfors.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2783345     DOI： 10.1016/s0022-3476(89)80611-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  24 in total

1.  Differential expression of Vibrio vulnificus capsular polysaccharide.

Authors:  A C Wright; J L Powell; M K Tanner; L A Ensor; A B Karpas; J G Morris; M B Sztein
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine.

Authors:  T Barington; K Kristensen; J Henrichsen; C Heilmann
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

3.  Immunogenicity and tolerance of H. influenzae type b, tetanus toxoid conjugate vaccine given concurrently or in combination.

Authors:  A Kumar; A K Dutta; A Saili; S Nangia; R Dutta
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

4.  Structural and antigenic conservation of the P2 porin protein among strains of Haemophilus influenzae type b.

Authors:  E J Hansen; S E Pelzel; K Orth; C R Moomaw; J D Radolf; C A Slaughter
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

5.  Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.

Authors:  R Booy; S A Taylor; S R Dobson; D Isaacs; G Sleight; S Aitken; H Griffiths; H Chapel; R T Mayon-White; J A Macfarlane
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

6.  Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.

Authors:  T Lagergard; J Shiloach; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

7.  Immunizations in pediatrics: an update.

Authors:  E L Ford-Jones; R Gold
Journal:  Can Fam Physician       Date:  1990-09       Impact factor: 3.275

8.  Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria.

Authors:  Margret Y Richter; Håvard Jakobsen; Alda Birgisdottir; Jean-François Haeuw; Ultan F Power; Giuseppe Del Giudice; Antonella Bartoloni; Ingileif Jonsdottir
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity.

Authors:  T Barington; L Juul; A Gyhrs; C Heilmann
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Qualitative and quantitative analyses of the antibody response elicited by Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in adults with IgG subclass deficiencies and frequent infections.

Authors:  M A Avanzini; J Björkander; R Söderström; T Söderström; R Schneerson; J B Robbins; L A Hanson
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.